Frailty as a predictor of poor outcomes among patients awaiting liver transplant: a systematic review and meta-analysis.
Gastroenterology and hepatology from bed to bench. · 01.01.2023 · 16 (4) · 364-377
DOI: 10.22037/ghfbb.v16i4.2795 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gastroenterology and hepatology from bed to bench., erschienen am 01.01.2023. Verfasst von Seyed Ali Moosavi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Aim
This review sought to evaluate the significance of a functional assessment for liver transplant candidates, i.e., frailty, in the pre-transplant setting and its association with mortality and morbidities.
Background
Liver transplantation (LT) remains the treatment of choice for patients with end-stage liver disease. Due to the shortage of organs for LT, a careful selection of suitable recipients is essential. Frailty, a measure of physiologic reserve and increased vulnerability to stressors, was initially used in geriatrics and then introduced to the field of transplantation for better patient selection.
Methods
PubMed, Scopus, and Web of Science databases were reviewed up until January 2023. The search terms included: "frail*", "liver", and "transplant*". A Meta-analysis was conducted for the hazard ratios (HRs) obtained from the COX regression models. Fifty-five studies were included in this review; ten were included in the meta-analysis.
Results
The prevalence of frailty varied from 2.82% to 70.09% in the studies. Meta-analysis showed that overall frailty had a significant association with mortality (pooled adjusted HR [95%CI]: 2.66 [1.96-3.63]). Subgroup analyses revealed that both the Liver Frailty Index and Fried Frailty Index were significantly associated with mortality. Furthermore, these studies have demonstrated that this population's frailty is associated with ascites, hepatic encephalopathy, and esophageal varices.
Conclusion
According to emerging evidence, frailty is associated with increased morbidity and mortality of the patients on the LT waiting list. Further randomized trials are required to determine the efficacy and safety of variable interventions in the frail population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- These authors contributed equally.
- Baylor University Medical Center, Baylor Scott & White Health, Dallas, Texas, United States.
- Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Zitieren
APA
Moosavi, S. A., Mashhadiagha, A., Taherifard, E., Fallahzadeh, M. A., Motazedian, N., Sayadi, M., Azarpira, N., & Rahimi, R. S. (2023). Frailty as a predictor of poor outcomes among patients awaiting liver transplant: a systematic review and meta-analysis. Gastroenterology and hepatology from bed to bench., 16(4), 364-377. https://doi.org/10.22037/ghfbb.v16i4.2795
Vancouver
Moosavi SA, Mashhadiagha A, Taherifard E, Fallahzadeh MA, Motazedian N, Sayadi M, et al. Frailty as a predictor of poor outcomes among patients awaiting liver transplant: a systematic review and meta-analysis. Gastroenterology and hepatology from bed to bench.. 2023;16(4):364-377. doi:10.22037/ghfbb.v16i4.2795
BibTeX
@article{Moosavi2023,
author = {Moosavi, Seyed Ali and Mashhadiagha, Amirali and Taherifard, Erfan and Fallahzadeh, Mohammad Amin and Motazedian, Nasrin and Sayadi, Mehrab and Azarpira, Negar and Rahimi, Robert S},
title = {Frailty as a predictor of poor outcomes among patients awaiting liver transplant: a systematic review and meta-analysis},
journal = {Gastroenterology and hepatology from bed to bench.},
year = {2023},
volume = {16},
number = {4},
pages = {364--377},
doi = {10.22037/ghfbb.v16i4.2795}
}
EUVIMED